CausalSentinel

Protein Dossier — POMGNT2 (Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Bulimia nervosa -0.082 0.0273 0.0027 Inverse variance weighted 2 trans NA
Bulimia nervosa -0.082 0.0273 0.0027 Inverse variance weighted 2 cis NA
Diagnoses - main ICD10: R07 Pain in throat and chest 0.0849 0.0317 0.00736 Inverse variance weighted 2 trans NA
Diagnoses - main ICD10: R07 Pain in throat and chest 0.0849 0.0317 0.00736 Inverse variance weighted 2 cis NA
Diagnoses - main ICD10: N92 Excessive frequent and irregular menstruation 0.109 0.0424 0.00988 Inverse variance weighted 2 trans NA
Diagnoses - main ICD10: N92 Excessive frequent and irregular menstruation 0.109 0.0424 0.00988 Inverse variance weighted 2 cis NA
Diagnoses - main ICD10: M23 Internal derangement of knee 0.104 0.0411 0.0118 Inverse variance weighted 2 trans NA
Diagnoses - main ICD10: M23 Internal derangement of knee 0.104 0.0411 0.0118 Inverse variance weighted 2 cis NA
Non-cancer illness code self-reported: hypothyroidism or myxoedema -0.0729 0.0324 0.0245 Inverse variance weighted 2 trans NA
Non-cancer illness code self-reported: hypothyroidism or myxoedema -0.0729 0.0324 0.0245 Inverse variance weighted 2 cis NA
Primary sclerosing cholangitis 0.194 0.0866 0.0253 Inverse variance weighted 2 trans NA
Primary sclerosing cholangitis 0.194 0.0866 0.0253 Inverse variance weighted 2 cis NA
…and 203 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

65 association rows across 37 traits (53 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransf 2e-257 rs4683355 2 GCST90249061 no MR -> candidate analysis
GASK1A protein levels 5e-106 rs73074963 15 GCST90469306 no MR -> candidate analysis
Serum levels of protein POMGNT2 3e-50 rs2936818 1 GCST90089363 no MR -> candidate analysis
Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransf 8e-34 rs79762832 1 GCST90238222 no MR -> candidate analysis
Blood protein levels 4e-30 rs729654 1 GCST006585 no MR -> candidate analysis
Height 8e-29 rs1320160 1 GCST90245848 no MR -> candidate analysis
Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransf 9e-27 rs729654 1 GCST90242495 no MR -> candidate analysis
CCL17 protein levels 2e-25 rs11719635 1 GCST90468569 no MR -> candidate analysis
Hematological traits (multi-trait analysis) 1e-23 rs60671097 2 GCST90838669 no MR -> candidate analysis
Insomnia 5e-17 rs9875582 8 GCST90131901 no MR -> candidate analysis
CCL7 protein levels 1e-14 rs11719635 1 GCST90468585 no MR -> candidate analysis
Externalizing behaviour (multivariate analysis) 3e-13 rs76887862 1 GCST90061435 no MR -> candidate analysis
…and 25 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 61 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8 0.896 established (curated) no MR -> candidate analysis
muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 8 0.796 established (curated) no MR -> candidate analysis
muscular dystrophy-dystroglycanopathy, type A 0.608 established (curated) no MR -> candidate analysis
hereditary disease 0.561 established (curated) no MR -> candidate analysis
ankylosing spondylitis 0.427 common-variant locus no MR -> candidate analysis
Severe hydrocephalus 0.426 established (curated) no MR -> candidate analysis
placenta praevia 0.324 common-variant locus no MR -> candidate analysis
ovarian neoplasm 0.309 common-variant locus no MR -> candidate analysis
response to antihypertensive drug 0.167 common-variant locus no MR -> candidate analysis
spondylolisthesis 0.106 common-variant locus no MR -> candidate analysis
ovarian dysfunction 0.088 common-variant locus no MR -> candidate analysis
insomnia 0.051 common-variant locus no MR -> candidate analysis
cleft palate 0.043 common-variant locus no MR -> candidate analysis
Hypercholesterolemia 0.041 common-variant locus MR: beta=0.0266, p=0.0635 (trans)
attention deficit-hyperactivity disorder 0.033 common-variant locus no MR -> candidate analysis

Of the 15 rows above, 14 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=5.5e-10, LOEUF=1.14 — LoF-tolerant
GWAS Catalog 101 unique SNPs / 179 rows
ClinVar 508 records; 4 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance